Patent Term Extension

ICR 201001-0651-002

OMB: 0651-0020

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Supplementary Document
2010-01-22
Supplementary Document
2010-01-22
Supporting Statement A
2007-09-26
Supplementary Document
2007-09-26
ICR Details
0651-0020 201001-0651-002
Historical Active 200709-0651-002
DOC/PTO E2010-01
Patent Term Extension
Revision of a currently approved collection   No
Emergency 01/27/2010
Approved without change 01/28/2010
Retrieve Notice of Action (NOA) 01/25/2010
  Inventory as of this Action Requested Previously Approved
07/31/2010 6 Months From Approved 02/28/2011
38,859 0 26,859
32,945 0 30,905
5,989,522 0 5,988,050

The Federal Food, Drug and Cosmetic Act of 35 U.S.C. 156 permits the USPTO to restore the patent term lost due to certain types of regulatory review by the Federal Food and Drug Administration or the Department of Agriculture. Only patents for drug products, medical devices, food additives, and color additives are eligible for an extension. Under 35 U.S.C. 154 the USPTO may also in some cases adjust the term of an original patent due to certain delays in the prosecution of the application. The information in this collection is used by the USPTO to consider whether an application is eligible for a patent term extension or reconsideration of a patent term adjustment, and if so, to determine the length of the patent term extension or adjustment.
The United States Patent and Trademark Office (USPTO) requests emergency review of an information collection request associated with 0651-0020 Patent Term Extension. A recent Federal Circuit Court decision has impacted the information collection activities. The USPTO is implementing a new procedure for patentees to seek a revised patent term adjustment in a patent if the patentee’s sole basis for requesting recalculation of the patent term adjustment in the patent is the USPTO’s pre-Wyeth interpretation of 35 U.S.C. 154(b)(2)(A).

US Code: 35 USC 154-156 Name of Law: Federal Food, Drug and Cosmetic Act
  
US Code: 35 USC 154(b) Name of Law: null

Not associated with rulemaking

  72 FR 35222 06/27/2007
72 FR 53233 09/18/2007
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 38,859 26,859 12,000 0 0 0
Annual Time Burden (Hours) 32,945 30,905 2,040 0 0 0
Annual Cost Burden (Dollars) 5,989,522 5,988,050 1,470 0 2 0
No
No
As a result of a recent Federal Circuit Court decision, the USPTO is implementing a new procedure for patentees to seek a revised patent term adjustment in a patent if the patentee’s sole basis for requesting recalculation of the patent term adjustment in the patent is the USPTO’s pre-Wyeth interpretation of 35 U.S.C. § 154(b)(2)(A). The new procedure permits eligible patentees to request a recalculation of their patent term adjustment in lieu of the petition and fee required by 37 CFR 1.705(d). The USPTO is proposing to add a new form for patentees to request recalculation of their patent term adjustments in light of Wyeth: Request for Recalculation of Patent Term Adjustment in View of Wyeth, Form PTO/SB/131. The addition of this form will add 12,000 responses, 2,040 burden hours, and $1,470 in annual cost burden to this collection as a program change. An administrative adjustment of $2 has also been made to account for a rounding difference in previously reported postage costs for this collection.

$509,369
No
No
Uncollected
Uncollected
No
Uncollected
Brian Hanlon 5712725047 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/25/2010


© 2024 OMB.report | Privacy Policy